Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,440.00
Bid: 1,431.00
Ask: 1,433.00
Change: 12.00 (0.84%)
Spread: 2.00 (0.14%)
Open: 1,439.00
High: 1,448.00
Low: 1,417.00
Prev. Close: 1,428.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indivior Names Promotes Finance Head Crossley To CEO, Thaxter Departs

Mon, 29th Jun 2020 10:29

(Alliance News) - Indivior PLC on Monday said Chief Financial & Operations Officer Mark Crossley will replace Shaun Thaxter as chief executive with immediate effect.

Thaxter, in mutual agreement with the board, is stepping down as chief executive and executive director, the company added.

Indivior shares were trading 0.5% lower at 78.40 pence each on Monday morning in London.

Crossley has been chief financial and operations officer of the drug manufacturer since February 2017. He was chief strategy officer from 2014 to 2017 and also served as finance director where he led the demerger of Indivior from Reckitt Benckiser Group PLC.

Indivior said Ryan Preblick has been appointed interim chief financial officer, adding that it will commence a search for a permanent finance chief and assess whether to hire a separate operations officer. Preblick is currently senior vice president Global Financial Planning & Analysis Commercial Operations, a role he stepped into in January. He joined Indivior in 2012 as regional finance controller for North America, later becoming vice president US Finance.

"Indivior's vision is to ensure patients all around the world have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Mark is a proven leader with a broad strategic and financial skill-set and a deep understanding of the company's guiding principles. The board has full confidence in his ability to drive Indivior forwards and to pursue its vision for the benefit of all stakeholders," said Interim Chair Daniel Tasse.

By Ife Taiwo; ifetaiwo@alliancenews.com.

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2021 10:41

Indivior raises profit and revenue guidance after strong start to year

Indivior raises profit and revenue guidance after strong start to year

Read more
30 Jun 2021 09:02

LONDON MARKET OPEN: Indivior shines after upgrading guidance

LONDON MARKET OPEN: Indivior shines after upgrading guidance

Read more
30 Jun 2021 07:58

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

Read more
30 Jun 2021 07:35

Indivior lifts 2021 guidance after better-than-expected H1

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its 2021 guidance on Wednesday following a better-than-expected business performance through the first half of the year.

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
8 Jun 2021 14:27

IN BRIEF: Indivior secures license for cannabis disorder treatment

IN BRIEF: Indivior secures license for cannabis disorder treatment

Read more
8 Jun 2021 12:36

Indivior teams up with Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
8 Jun 2021 12:36

Indivior joins forces with France's Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
6 May 2021 17:50

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

Read more
29 Apr 2021 16:11

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Apr 2021 12:26

Indivior maintains 2021 guidance as first quarter revenue increases

Indivior maintains 2021 guidance as first quarter revenue increases

Read more
28 Apr 2021 10:47

Indivior says US filings "administrative", no new Suboxone settlements

Indivior says US filings "administrative", no new Suboxone settlements

Read more
22 Apr 2021 16:10

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
24 Mar 2021 10:11

Indivior revamps board after accord with biggest shareholder Scopia

Indivior revamps board after accord with biggest shareholder Scopia

Read more
24 Mar 2021 07:56

Indivior puts biggest investor on board in overhaul

(Sharecast News) - Indivior has given Scopia Capital, its biggest investor, a place on its board as part of a governance overhaul by the prescription drugs group.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.